0001209191-14-062657.txt : 20141015 0001209191-14-062657.hdr.sgml : 20141009 20141009164133 ACCESSION NUMBER: 0001209191-14-062657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141007 FILED AS OF DATE: 20141009 DATE AS OF CHANGE: 20141009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Calithera Biosciences, Inc. CENTRAL INDEX KEY: 0001496671 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272366329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-870-1000 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christoffersen Ralph E CENTRAL INDEX KEY: 0001316252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36644 FILM NUMBER: 141150488 MAIL ADDRESS: STREET 1: 4430 ARAPAHOE AVENUE STREET 2: SUITE 200 CITY: BOULDER STATE: CO ZIP: 80303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-10-07 0 0001496671 Calithera Biosciences, Inc. CALA 0001316252 Christoffersen Ralph E 2710 SAND HILL ROAD, SUITE 100 MENLO PARK CA 94025 1 0 1 0 COMMON STOCK 2014-10-07 4 C 0 1811915 A 1811915 I By Partnership COMMON STOCK 2014-10-07 4 P 0 350000 10.00 A 2161915 I By Partnership SERIES A PREFERRED STOCK 2014-10-07 4 C 0 10999 0.00 A COMMON STOCK 10999 0 I See Footnote SERIES B PREFERRED STOCK 2014-10-07 4 C 0 419181 0.00 A COMMON STOCK 419181 0 I See Footnote SERIES C PREFERRED STOCK 2014-10-07 4 C 0 747540 0.00 A COMMON STOCK 747540 0 I See Footnote SERIES D PREFERRED STOCK 2014-10-07 4 C 0 634195 0.00 A COMMON STOCK 634195 0 I See Footnote The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately upon consummation of Issuer's initial public offering of Common Stock and had no expiration date. The securities are held by Morgenthaler Venture Partners IX, L.P. (MVP IX). The managing partner of MVP IX is Morgenthaler Management Partners IX, LLC (MMP IX). Ralph E. Christoffersen, a director of the Issuer is a Member of MMP IX. As such, the Reporting Person shares voting and investment power over the securities held by MMP IX. The Reporting Person disclaims beneficial ownership of the securities held by MMP IX except to the extent of his pecuniary interest therein. /s/ Ralph E. Christoffersen 2014-10-09